Kwok-Yung Yuen to Drug Discovery
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Drug Discovery.
Connection Strength
0.434
-
Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 05; 15(5):327-47.
Score: 0.225
-
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. Nat Commun. 2021 03 09; 12(1):1517.
Score: 0.080
-
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antiviral Res. 2017 Sep; 145:33-43.
Score: 0.062
-
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 2013 Dec; 67(6):606-16.
Score: 0.048
-
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. Int J Biol Sci. 2021; 17(6):1555-1564.
Score: 0.020